Recent Entries

  • The TIL-based therapies market is projected to be worth over US

    Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status   Roots Analysis has announced the additio...
  • The polycystic ovary syndrome market is growing at an annualize

    polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors   Roots Analysis is pleased to announce the publication of its recent study, title...
  • Patient Recruitment and Retention Services Marker

    A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers   Roots Analysis  is pleased to announce the public...
  • STING Pathway Targeting Therapeutics and Technologies, 2020-203

    STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies   Roots Analysis is pleased to announce the publication of its re...
  • Large Volume Wearable Injectors Market by Roots Analysis

    Over the years, a rise in preference for self-administrable drugs / therapies has resulted in an increasing demand for user-friendly drug delivery solutions that are not only safe and efficient, but also promote therapy adherence   London   Roots Analysis has announced the addition of ...
  • Presently, close to 140 companies claim to be actively engaged

    A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering pati...
  • Human Microbiome-based Products Market, growing at an annualize

    Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic   Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030&rdqu...
  • The antibody contract manufacturing market is projected to reac

    With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone   Roots Analysis has announced the addition of the “Ant...